![](/img/cover-not-exists.png)
Cost-Effectiveness of Nivolumab (NIVO) Combined with Ipilimumab (IPI) Compared with Nivo and Ipi Monotherapies in The First-Line Treatment of Advanced Melanoma in The United States: Analysis Using 28-Month Overall Survival (OS) Data from Checkmate 067
Baker, T, Paly, VF, Sabater, J, Gupte-Singh, K, Beyhaghi, H, Kotapati, S, Rao, S, Briggs, AVolume:
20
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2017.08.218
Date:
October, 2017
File:
PDF, 62 KB
english, 2017